Obesity

"Obesity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Descriptor ID	D009765
MeSH Number(s)	C18.654.726.500 C23.888.144.699.500 E01.370.600.115.100.160.120.699.500 G07.100.100.160.120.699.500
Concept/Terms	Obesity Obesity

Below are MeSH descriptors whose meaning is more general than "Obesity".

Diseases [C]
Nutritional and Metabolic Diseases [C18]
Nutrition Disorders [C18.654]
Overnutrition [C18.654.726]
Obesity [C18.654.726.500]
Pathological Conditions, Signs and Symptoms [C23]
Signs and Symptoms [C23.888]
Body Weight [C23.888.144]
Overweight [C23.888.144.699]
Obesity [C23.888.144.699.500]
Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Physical Examination [E01.370.600]
Body Constitution [E01.370.600.115]
Body Weights and Measures [E01.370.600.115.100]
Body Size [E01.370.600.115.100.160]
Body Weight [E01.370.600.115.100.160.120]
Overweight [E01.370.600.115.100.160.120.699]
Obesity [E01.370.600.115.100.160.120.699.500]
Biological Sciences [G]
Physiological Phenomena [G07]
Body Constitution [G07.100]
Body Weights and Measures [G07.100.100]
Body Size [G07.100.100.160]
Body Weight [G07.100.100.160.120]
Overweight [G07.100.100.160.120.699]
Obesity [G07.100.100.160.120.699.500]

Below are MeSH descriptors whose meaning is related to "Obesity".

Below are MeSH descriptors whose meaning is more specific than "Obesity".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Obesity" by people in this website by year, and whether "Obesity" was a major or minor topic of these publications.

Bar chart showing 874 publications over 30 distinct years, with a maximum of 74 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	1	3
1997	2	2	4
1998	3	0	3
1999	5	1	6
2000	1	1	2
2001	5	4	9
2002	9	3	12
2003	14	7	21
2004	15	11	26
2005	18	4	22
2006	16	3	19
2007	22	10	32
2008	24	11	35
2009	26	13	39
2010	35	8	43
2011	39	9	48
2012	25	10	35
2013	55	19	74
2014	39	18	57
2015	43	19	62
2016	20	32	52
2017	42	13	55
2018	18	13	31
2019	26	11	37
2020	20	14	34
2021	8	19	27
2022	3	29	32
2023	4	21	25
2024	14	12	26
2025	2	1	3

Below are the most recent publications written about "Obesity" by people in Profiles.

Fath AR, Aglan A, Maron MS, Phillips JS, Maron BJ, Rowin EJ. Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy. Int J Cardiol. 2025 May 01; 426:133082.

View in: PubMed
Cicu?ndez B, Mora A, L?pez JA, Curtabbi A, P?rez-Garc?a J, Porteiro B, Jimenez-Blasco D, Latorre-Muro P, Vo P, Jerome M, G?mez-Santos B, Romero-Becerra R, Leiva M, Rodr?guez E, Le?n M, Leiva-Vega L, G?mez-Lado N, Torres JL, Hern?ndez-Cosido L, Aguiar P, Marcos M, Jastroch M, Daiber A, Aspichueta P, Bola?os JP, Spinelli JB, Puigserver P, Enriquez JA, V?zquez J, Folgueira C, Sabio G. Absence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis. Nat Commun. 2025 Jan 13; 16(1):229.

View in: PubMed
Bea JW, Ochs-Balcom HM, Valencia CI, Chen Z, Blew RM, Lind KE, Caan BJ, Roe DJ, Rohan TE, Reeves KW, Manson JE, Ballinger T, Reding KW, Follis S, Ziller SG, Odegaard AO. Abdominal visceral and subcutaneous adipose tissue associations with postmenopausal breast cancer incidence. JNCI Cancer Spectr. 2025 Jan 03; 9(1).

View in: PubMed
Pagoto S, Xu R, Bannor R, Idiong C, Goetz J, Fernandes D. Comparing Synchronous and Asynchronous Remotely Delivered Lifestyle Interventions: Protocol for a Randomized Noninferiority Trial. JMIR Res Protoc. 2024 Dec 19; 13:e65323.

View in: PubMed
Yuzefovych LV, Noh HL, Suk S, Schuler AM, Mulekar MS, Pastukh VM, Kim JK, Rachek LI. Mitochondria-Targeted DNA Repair Glycosylase hOGG1 Protects Against HFD-Induced Liver Oxidative Mitochondrial DNA Damage and Insulin Resistance in OGG1-Deficient Mice. Int J Mol Sci. 2024 Nov 13; 25(22).

View in: PubMed
Bai MR, Abirami K, Gayathri R, Vedantham S, Shobana S, Nagarajan LP, Gunasekaran G, Nagamuthu G, Malini HM, Gokulakrishnan K, Sandhya N, Ganesh Jeevan R, Anjana RM, Unnikrishnan R, Krishnaswamy K, Sudha V, Mohan V. Effect of low vs high dietary-advanced glycation end products on insulin-sensitivity and inflammatory- markers among overweight/obese Asian-Indian adults-A randomised controlled trial. Int J Food Sci Nutr. 2024 Dec; 75(8):835-845.

View in: PubMed
Ayyaswami V, Subramanian J, Nickerson J, Erban S, Rosano N, McManus DD, Gerber BS, Faro JM. A Clinician and Electronic Health Record Wearable Device Intervention to Increase Physical Activity in Patients With Obesity: Formative Qualitative Study. JMIR Form Res. 2024 Sep 02; 8:e56962.

View in: PubMed
Patel R, Wadid M, Makwana B, Kumar A, Khadke S, Bhatti A, Banker A, Husami Z, Labib S, Venesy D, Fonarow G, Kosiborod M, Al-Kindi S, Bhatt DL, Dani S, Nohria A, Butler J, Ganatra S. GLP-1 Receptor Agonists Among Patients?With Overweight or Obesity,?Diabetes,?and HFpEF on SGLT2?Inhibitors. JACC Heart Fail. 2024 Nov; 12(11):1814-1826.

View in: PubMed
Pagoto SL, Goetz JM, Xu R, Wang ML, Palmer L, Lemon SC. Randomized non-inferiority trial comparing an asynchronous remotely-delivered versus clinic-delivered lifestyle intervention. Int J Obes (Lond). 2025 Jan; 49(1):76-83.

View in: PubMed
Wagner KA, Pekow P, Marcus B, Rosal MC, Braun B, Manson JE, Whitcomb BW, Sievert LL, Chasan-Taber L. The Impact of a Lifestyle Intervention on Cardiometabolic Risk Factors among Postpartum Hispanic Women with Overweight and Obesity in a Randomized Controlled Trial (Proyecto Mam?). Matern Child Health J. 2024 Oct; 28(10):1768-1781.

View in: PubMed

People

Explore

Similar Concepts

Top Journals